parametric pearson chi square tests (CH Instruments)
90
Structured Review
CH Instruments
parametric pearson chi square tests
Parametric Pearson Chi Square Tests, supplied by CH Instruments, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/parametric+pearson%E2%80%99s+chi-square+test/parametric+t+test/pmc11752022__bmjopen___2024___089642__reviewer_comments-26-9-10
Average 90 stars, based on 1 article reviews
Parametric Pearson Chi Square Tests, supplied by CH Instruments, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/parametric+pearson%E2%80%99s+chi-square+test/parametric+t+test/pmc11752022__bmjopen___2024___089642__reviewer_comments-26-9-10
Average 90 stars, based on 1 article reviews
parametric pearson chi square tests - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
Staining:Article Title: Mutant p53 potentiates the oncogenic effects of insulin by inhibiting the tumor suppressor DAB2IP Article Snippet: Tumors with p-AKT staining >15% have been classified as “positive.” Correlations were analyzed by a parametric Pearson’s chi-square test (P-val). ( D ) Proposed model for the gain of function of mutant p53 in the response to insulin as mediated by its cytoplasmic interaction with DAB2IP. Mutagenesis:Article Title: Mutant p53 potentiates the oncogenic effects of insulin by inhibiting the tumor suppressor DAB2IP Article Snippet: Tumors with p-AKT staining >15% have been classified as “positive.” Correlations were analyzed by a parametric Pearson’s chi-square test (P-val). ( D ) Proposed model for the gain of function of mutant p53 in the response to insulin as mediated by its cytoplasmic interaction with DAB2IP. Activation Assay:Article Title: Mutant p53 potentiates the oncogenic effects of insulin by inhibiting the tumor suppressor DAB2IP Article Snippet: Tumors with p-AKT staining >15% have been classified as “positive.” Correlations were analyzed by a parametric Pearson’s chi-square test (P-val). ( D ) Proposed model for the gain of function of mutant p53 in the response to insulin as mediated by its cytoplasmic interaction with DAB2IP. Immunostaining:Article Title: Mutant p53 potentiates the oncogenic effects of insulin by inhibiting the tumor suppressor DAB2IP Article Snippet: Tumors with p-AKT staining >15% have been classified as “positive.” Correlations were analyzed by a parametric Pearson’s chi-square test (P-val). ( D ) Proposed model for the gain of function of mutant p53 in the response to insulin as mediated by its cytoplasmic interaction with DAB2IP. Derivative Assay:Article Title: Mutant p53 potentiates the oncogenic effects of insulin by inhibiting the tumor suppressor DAB2IP Article Snippet: Tumors with p-AKT staining >15% have been classified as “positive.” Correlations were analyzed by a parametric Pearson’s chi-square test (P-val). ( D ) Proposed model for the gain of function of mutant p53 in the response to insulin as mediated by its cytoplasmic interaction with DAB2IP. MANN-WHITNEY:Article Title: Mutant p53 potentiates the oncogenic effects of insulin by inhibiting the tumor suppressor DAB2IP Article Snippet: Tumors with p-AKT staining >15% have been classified as “positive.” Correlations were analyzed by a parametric Pearson’s chi-square test (P-val). ( D ) Proposed model for the gain of function of mutant p53 in the response to insulin as mediated by its cytoplasmic interaction with DAB2IP. Immunohistochemical staining:Article Title: Mutant p53 potentiates the oncogenic effects of insulin by inhibiting the tumor suppressor DAB2IP Article Snippet: Tumors with p-AKT staining >15% have been classified as “positive.” Correlations were analyzed by a parametric Pearson’s chi-square test (P-val). ( D ) Proposed model for the gain of function of mutant p53 in the response to insulin as mediated by its cytoplasmic interaction with DAB2IP. Software:Article Title: Mutant p53 potentiates the oncogenic effects of insulin by inhibiting the tumor suppressor DAB2IP Article Snippet: Tumors with p-AKT staining >15% have been classified as “positive.” Correlations were analyzed by a parametric Pearson’s chi-square test (P-val). ( D ) Proposed model for the gain of function of mutant p53 in the response to insulin as mediated by its cytoplasmic interaction with DAB2IP. Expressing:Article Title: Mutant p53 potentiates the oncogenic effects of insulin by inhibiting the tumor suppressor DAB2IP Article Snippet: Tumors with p-AKT staining >15% have been classified as “positive.” Correlations were analyzed by a parametric Pearson’s chi-square test (P-val). ( D ) Proposed model for the gain of function of mutant p53 in the response to insulin as mediated by its cytoplasmic interaction with DAB2IP. |
![AKT activation correlates with p53 mutation in triple-negative breast cancers of obese patients. (A) Immunostaining with antibodies against p53 and p-AKT S473 of representative triple-negative breast cancer sections derived from obese and nonobese patients. H, hematoxylin staining. (Scale bars: 100 μm.) (B) Graphs summarize p-AKT S473 staining in tumor samples from 32 obese patients [body mass index (BMI) > 30] and 20 nonobese patients, sorted according to p53 status. The horizontal bar indicates the median. Correlations were analyzed by a nonparametric Mann–Whitney U test. (C) Table summarizes the same tumor samples as in B, grouped according to p53 status and p-AKT S473 staining. Tumors with p53 staining >80% have been classified as mutant p53. Tumors with p-AKT staining >15% have been classified as “positive.” Correlations were analyzed by a parametric <t>Pearson’s</t> chi-square test (P-val). (D) Proposed model for the gain of function of mutant p53 in the response to insulin as mediated by its cytoplasmic interaction with DAB2IP.](https://pub-med-central-images-cdn.bioz.com/pub_med_central_ids_ending_with_0663/pmc05530663/pmc05530663__pnas.1700996114fig05.jpg)